Cognitive-behavioral therapy for depression;Terapia cognitivo-comportamental da depressão

Revista Brasileira de Psiquiatria

Volumn 30, Issue SUPPL. 2, 2008, Pages

  Powell, Vania Bitencourt ^a   Abreu, Neander ^b   De Oliveira, Irismar Reis ^c   Sudak, Donna ^d  

^a ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^b UNIVERSIDADE FEDERAL DO RECÔNCAVO DA BAHIA   (Brazil)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^d DREXEL UNIVERSITY   (United States)

Author keywords

Cognitive therapy; Depression; Depressive disorder, major; Drug therapy; Epidemiology

Indexed keywords

ANTIDEPRESSANT AGENT; IMIPRAMINE; NEFAZODONE; PLACEBO;

BEHAVIOR MODIFICATION; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; DEPRESSION; EMPIRICAL RESEARCH; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; META ANALYSIS; RELAPSE; REMISSION; REVIEW; THERAPY EFFECT; TREATMENT DURATION;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; COGNITIVE THERAPY; DEPRESSIVE DISORDER; HUMANS; IMIPRAMINE; RECURRENCE; TREATMENT OUTCOME;

EID: 57349147127     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462008000600004     Document Type: Review

References (60)

1. Murray CJ, Lopez AD, editors. The global burden of disease series. Boston, MA: Harvard School of Public Health; 1996.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV-TR). 4th Edition Text Revision. Washington (DC): American Psychiatric Association; 2000.
3. Klein D. Diagnosis and classification of dysthymic disorder. In: Kocsis JH, Klein DN, editors. Diagnosis and treatment of chronic depression. New York: Guilford; 1995.
4. World Health Organization (WHO). ICD-10. International statistical classification of diseases and related health problems (10th edition). Geneva, SR: World Health Organization (WHO); 1992.
5. Thase ME. Pharmacotherapy of bipolar depression: an update. Curr Psychiatr Rep. 2006;8:478-88.
6. American Psychiatry Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th edition. Washington (DC): American Psychiatric Association; 1994.
7. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS; National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National. Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-105.
8. Kennedy SH, Lam RW, Nutt DJ, Thase ME. Psychotherapies, alone and in combination. In: Kennedy SH, Lam RW, Nutt DJ, Thase ME, editors. Treating depression effectively: applying clinical guidelines. London: Martin Dunitz; 2004.
9. Byrne SE, Rothschild AJ. Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments. J Clin Psychiatry. 1998;59(6):279-88.
10. Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. Am J Psychiatry. 2000;157(12):1925-32.
11. Antonuccio DO, Danton WG, DeNelsky GY. Psychotherapy versus medication for depression: challenging the conventional wisdom with data. Prof Psychol Res Pract. 1995;26(6):574-85.
12. Fava GA, Grandi S, Zielezny M, Rafanelli C, Canestrari R. Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry. 1996;153(7):945-7.
13. Fava GA, Rafanelli C, Grandi S, Conti S, Belluardo P. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Arch Gen Psychiatry. 1998;55(9):816-20.
14. Fava GA, Rafanelli C, Grandi S, Canestrari R, Morphy MA. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry. 1998;155(10):1443-5.
15. Hollon SD, Jarrett RB, Nierenberg AA, Thase ME, Trivedi M, Rush AJ. Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry. 2005;66(4):455-68.
16. Beck AT. Thinking and depression. Arch Gen Psychiatry. 1963;9:324-33.
17. Beck AT. Depression: causes and treatment. Philadelphia: University of Pennsylvania Press; 1967.
18. Beck AT. The current state of cognitive therapy: a 40-year retrospective. Arch Gen Psychiatry. 2005;62(9):953-9.
19. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006;26(1):17-31.
20. Dobson KS. A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol. 1989;57(3):414-9.
21. Hollon SD, Shelton RC, Loosen PT. Cognitive therapy and pharmacotherapy for depression. J Consult Clin Psychol. 1991;59(1):88-99.
22. Beck AT. Cognitive therapy and the emotional disorders. Boston: International University Press; 1976.
23. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York: Guilford Press; 1979.
24. Beck JS. Cognitive therapy: basics and beyond. New York: Guilford Press; 1995.
25. Scher CD, Segal ZV, Ingram RE. Beck's theory of depression: origins, empirical status, and future directions for cognitive vulnerability. In: Leahy RL, editor. Contemporary cognitive therapy: theory, research, and practice. New York: Guilford Press; 2006.
26. Rupke SJ, Blecke D, Renfrow M. Cognitive therapy for depression. Am Fam Phys. 2006;73(1):83-6.
27. Leahy RL. Cognitive therapy techniques: a practitioner's guide. New York: Guilford Press; 2003.
28. Lewinsohn PM. A behavioral approach to depression. In: Friedman RM, Katz MM, editors. The psychology of depression. Contemporary theory and research. Washington, DC: Winston-Wiley; 1974.
29. Lewinsohn PM. The behavioral study and treatment of depression. In: Hersen M, Eisler RM, Miller PM, editors. Progress in behavior modification. Vol. 1. New York: Academic Press; 1975.
30. Sudak DM. Cognitive behavioral therapy for clinicians. Philadelphia: Lippincott, Williams & Wilkins; 2006.
31. Padesky CA, Greenberger D. Clinician's guide to mind over mood. New York: Guilford Press; 1995.
32. de Oliveira IR. Trial-Based Thought Record (TBTR): preliminary data on a strategy to deal with core beliefs by combining sentence reversion and the use of analogy with a judicial process. Rev Bras Psiquiatr. 2008;30(1):12-8.
33. Kafka F. The trial. New York: Schocken; 1998.
34. Burns DD. Feeling good: the new mood therapy. New York: Signet; 1980.
35. Freeman A, DeWolf R. The 10 dumbest mistakes smart people make and how to avoid them. New York: Harper Perennial; 1992.
36. De-Oliveira IR. Sentence-reversion-based thought record (SRBTR): a new strategy to deal with "yes, but..." dysfunctional thoughts in cognitive therapy. Eur Rev Appl Psychol. 2007;57:17-22.
37. Blenkiron P. Who is suitable for cognitive therapy behavioural therapy? J R Soc Med. 1999;92(5):222-9.
38. Deckrsbach T, Gershuny BS, Otto MW. Cognitive-behavioral therapy for depression. Psychiatr Clin North Am. 2000;23(4):795-809.
39. Teasdale JD, Moore RG, Hayhurst H, Pope M, Williams S, Segal ZV. Metacognitive awareness and prevention of relapse in depression: empirical evidence. J Consult Clin Psychol. 2002;70(2):275-87.
40. Blackburn IM, Eunson KM, Bishop S. A 2-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. J Affect Disord. 1986;10(1):67-75.
41. Murphy GE, Simons AD, Wetzel RD, Lustman PJ. Cognitive therapy and pharmacotherapy. Singly and together in the treatment of depression. Arch Gen Psychiatry. 1984;41(1):33-41.
42. Rush AJ, Beck AT, Kovacs M, Hollon SD. Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed out-patients. Cog Ther Res. 1977;1:17-37.
43. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilokins PA, Leber WR, Docerty JP. National Institute of Mental Health treatment of depression collaborative research program. General effectiveness of treatments. Arch Gen Psychiatry. 1989;46(11):971-82.
44. DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD. Medications versus cognitive-behavioral therapy for severely depressed outpatients: mega-analysis of four randomized comparisons. Am J Psychiatry. 1999;156(7):1007-13.
45. DeRubeis RJ, Feeley M. Determinants of change in cognitive therapy for depression. Cog Ther Res. 1990;14:464-82.
46. Jarrett RB, Schaffer M, McIntire D, Witt-Browder A, Kraft D, Risser RC. Treatment of atypical depression with cognitive therapy or phenelzine. Arch Gen Psychiatry. 1999;56:431-7.
47. Hollon SD, DeRubeis RJ, Evans MD, Wiemer MY, Garvey MS, Grove WM, Tuason VB. Cognitive therapy and pharmacoptherapy for depression. Singly and in combination. Arch Gen Psychiatry. 1992;49(10):774-81.
48. Greenberg RP, Fisher S. Mood mending medicines: probing drug, psychotherapy and placebo solutions. In: Fisher S, Greenberg RP, editors. From placebo to panacea: putting psychiatric drugs to the test. New York: John Wiley & Sons; 1997.
49. Greenberg, RP, Fisher S. Examining antidepressant effectiveness: findings, ambiguities, and some vexing puzzles. In: Fisher S, Greenberg RP, editors. The limits of biological treatments for psychological distress. Hillsdale (NJ): Erlbaum; 1989.
50. de Oliveira IR. The treatment of unipolar major depression: pharmacotherapy, cognitive behaviour therapy or both? J Clin Pharm Ther. 1998;23(6):467-75.
51. Conte HR, Plutchik R, Wild KV, Karasu TB. Combined psychotherapy and pharmacotherapy for depression. A systematic analysis of the evidence. Arch Gen Psychiatry. 1986;43(5):471-9.
52. Robinson LA, Berman JS, Neimeyer RA. Psychotherapy for the treatment of depression: a comprehensive review of controlled outcome research. Psychol Bull. 1990;108(1):30-49.
53. Wexler BE, Cicchetti DV. The outpatient treatment of depression. Implications of outcome research for clinical practice. J Nerv Ment Dis. 1992;180(5):277-86.
54. de Jonghe F, Kool S, van Aalst G, Dekker J, Peen J. Combining psychotherapy and antidepressants in the treatment of depression. J Affect Dis. 2001;64(2-3):217-29.
55. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Eng J Med. 2000;342:1462-70.
56. Friedman ES, Wright JH, Jarrett RB, Thase ME. Combining cognitive therapy and medication for mood disorders. Psychiatr Ann. 2006;36:320-8.
57. DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Saloman RM, O'Reardon JP, Lovett ML, Gladis MM, Brown LL, Gallop R. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005;62(4):409-16.
58. Bockting C, ten Doesschate MC, Spijker J, Spinhoven P, Koeter MW, Schene AH: DELTA Study Group. Continuation and maintenance use of antidepressants in recurrent depression. Psychother Psychosom. 2008;77(1):17-26.
59. Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, Jenaway A, Cornwall PL, Hayhurst H, Abbott R, Pope M. Prevention of relapse in residual depression by cognitive therapy. Arch Gen Psychiatry. 1999;56(9):829-35.
60. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000;68(4):615-23.